Drug Search Results
More Filters [+]

Polihexanide

Alternative Names: polihexanide
Latest Update: 2024-06-03
Latest Update Note: News Article

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Nondrug

Route of Administration: Subcutaneous,Topical,Nasal

FDA Designation: Orphan Drug - Keratitis *

Approval Status: Not Approved

Approved Countries: New Zealand | Slovenia | South Africa | Switzerland | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Johannes Lauscher
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Polihexanide

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Surgical Wound Infection

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2017-000152-26

P3

Completed

Surgical Wound Infection

2022-07-27

Recent News Events